Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Parkinson Disease Tomorrow: Evaluation of New Targets and Formulations
  • CME
  • CE

Credits Available
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit
Released: January 24, 2022 Expiration: January 23, 2023
Start Activity
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AbbVie
Tatyana Simuni, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify the mechanisms and contributors to the development of motor complications in Parkinson disease
  • Critically evaluate safety and efficacy data for emerging therapies for the treatment of wearing off
  • Summarize how novel formulations of adjunctive therapies for wearing off may be integrated into clinical practice

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Tatyana Simuni, MD

Arthur C. Nielsen Professor of Neurology
Division Head

Parkinson Disease and Movement Disorders Center
Northwestern University
Chicago, Illinois

Tanya Simuni, MD, has disclosed that she has received consulting fees from Acadia, Caraway, Denali, General Electric, Neuroderm, Roche, Sanofi, Sinopia, Sunovion, Takeda, and Voyager; funds for research support from Amneal, Biogen, Neuroderm, Roche, Sanofi, Sun Pharma, Prevail, and UCB; and other financial or material support from Acadia, Denali, General Electric, Roche, and Sunovion.

Staff

Julie Skowronski, FNP-BC
Julie Skowronski, NP, has no relevant conflicts of interest to report.
Mark Christiansen, PhD, PA-C
Mark Christiansen, PA-C, has no relevant conflicts of interest to report.
Lisa Phipps, PharmD, PhD
Lisa Phipps, PharmD, PhD, has no relevant conflicts of interest to report.
Aditi Nadkarni, PhD
Aditi Nadkarni, PhD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for a multidisciplinary audience of neurologists, primary care physicians, nurses, physician assistants, and other members of the healthcare team involved in the management of patients with movement disorders.

Goal

The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of movement disorders.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until January 23, 2023. PAs should only claim commensurate with the extent of their participation.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 24, 2022, through January 23, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Parkinson Disease Tomorrow: Evaluation of New Targets and Formulations
  • CME
  • CE

Loading...
In this interactive recording of a live CCO webinar, Tanya Simuni, MD, discusses safety and efficacy data for emerging therapies for the treatment of wearing off and how novel formulations of adjunctive therapies for wearing off may be integrated into clinical practice.
Tatyana Simuni, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit
Released: January 24, 2022 Expiration: January 23, 2023

Related Content

Slides from a presentation that educates clinicians on the identification and management of tardive dyskinesia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Dr Christoph U. Correll: Bold Panoramic Grasp of Tardive Dyskinesia at the Inaugural Psychiatry Summit 2022, from Clinical Care Options (CCO)

Christoph U. Correll, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category 1 CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: April 19, 2022 Expired: April 18, 2023

Slides from a presentation that educates clinicians on tardive dyskinesia.

Christoph U. Correll, MD Released: March 23, 2022

Slides from a presentation that educates clinicians on myth busting in psychopharmacology

Leslie Citrome, MD, MPH Released: March 22, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AbbVie

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings